Systemic Scleroderma

This is the general name for Scleroderma. It's a long-term condition that affects many parts of your body, including your skin, lungs, heart, and blood vessels. It causes the skin to become hard and tight.

Condition

What people with Systemic Scleroderma report

Every report comes from a Lived member, sent anonymously.

Have you tried Mycophenolic Acid for Systemic Scleroderma?

NameHow it went

About Systemic Scleroderma

What It Is

Systemic scleroderma, also called systemic sclerosis, is an autoimmune disease: the immune system mistakenly attacks the body's own tissues. This damages small blood vessels and prompts cells to make too much collagen, the protein that gives skin and organs their structure. The result is thick, tight, hardened skin and, in many people, scarring or blood vessel damage in internal organs such as the lungs, heart, kidneys and digestive tract. Common early signs include Raynaud's phenomenon (fingers or toes that turn white or blue, then red, and feel numb or painful in the cold or under stress), puffy fingers, tight skin on the fingers, fatigue, joint pain and stiffness, heartburn and trouble swallowing. Some people later notice shortness of breath as the lungs become involved. Doctors describe two main forms based on how much skin is affected. In limited cutaneous systemic sclerosis, the more common form (about two in three people), less of the skin is involved. In diffuse cutaneous systemic sclerosis, skin thickening spreads more widely and serious organ problems are more likely to develop early. Organ complications can still occur in either form, which is why everyone with the diagnosis needs regular checks. Systemic scleroderma is different from localized scleroderma (such as morphea), which affects only the skin and the tissue just beneath it.

Causes & Risk Factors

The cause of systemic scleroderma is not known. Researchers think it develops when inherited tendencies combine with something in a person's surroundings that sets off the immune system. Certain chemicals, viruses and medicines have been suggested as possible triggers, but for most people no trigger is ever found. Having a close relative with scleroderma raises the chance somewhat, although the disease is not passed directly from parent to child. It is more common in women than in men and usually begins between the ages of 30 and 50. It affects people of all racial and ethnic groups but is more common, and can be more severe, in African American people. Onset in childhood is possible but extremely rare.

How It's Diagnosed

No single test diagnoses systemic scleroderma. Its early symptoms (Raynaud's, heartburn, tiredness, aching joints) are common and have many other causes, so diagnosis is often delayed. Raynaud's is frequently the first clue, sometimes appearing years before anything else, and puffy fingers alongside Raynaud's are a particular reason to look further. A rheumatologist (a specialist in autoimmune and joint diseases) examines the skin and asks about symptoms, then orders blood tests. An antinuclear antibody (ANA) test looks for the general kind of antibody found in autoimmune diseases. More specific scleroderma antibodies help confirm the diagnosis and also hint at which complications are more likely: anti-topoisomerase I (also called anti-Scl-70) is linked with lung scarring, for example, and anti-RNA polymerase III with kidney problems. Doctors also look at the tiny blood vessels at the base of the fingernails with a magnifier (nailfold capillaroscopy). Characteristic changes there help separate scleroderma-related Raynaud's from the more common form that is not linked to any underlying disease. Once the diagnosis is made, testing continues. Everyone should have a baseline high-resolution CT scan of the chest (a detailed X-ray scan that can show early lung scarring) and pulmonary function tests, breathing tests that measure how much air the lungs hold and how well they pass oxygen into the blood. Heart and lung screening is then repeated every year, usually with breathing tests, an echocardiogram (an ultrasound of the heart) and blood tests, to catch lung scarring, pulmonary hypertension (high pressure in the arteries of the lungs) and heart involvement early, often before they cause symptoms. Blood pressure and kidney function are checked regularly too.

Treatment Options

There is currently no cure for systemic scleroderma, and no medicine is approved specifically to reverse skin thickening. Treatment instead targets whatever parts of the body are affected: calming the immune system where it is driving damage, protecting the organs, and easing symptoms. Because the disease is uncommon and varies so much, care is best led by a rheumatologist experienced in scleroderma, working with lung, heart, kidney and digestive specialists. For early diffuse disease and for lung scarring (interstitial lung disease), the usual first choice is mycophenolate mofetil (CellCept), a medicine that suppresses the immune system; methotrexate is an alternative for the skin. These medicines raise the risk of infection and need regular blood tests, and both mycophenolate and methotrexate can cause miscarriage and birth defects, so pregnancy has to be planned with the care team (which also advises men taking them about contraception). When lung disease is significant or getting worse, stronger immune-targeting treatments are options: tocilizumab (Actemra), a biologic (a lab-made antibody that blocks one immune signal) given as a weekly injection under the skin, and rituximab or cyclophosphamide, which are given by infusion. Nintedanib (Ofev) works differently: it is an antifibrotic pill that slows scarring. Tocilizumab and nintedanib are approved in the US to slow the loss of lung function in this disease. They slow decline rather than restore function already lost. A small group of people with early, rapidly worsening diffuse disease may be offered a stem cell transplant using their own cells. In trials it controlled the disease better than standard immune suppression with cyclophosphamide, but it carries serious risks, including death, so it is done only at experienced centers in carefully selected people. Other treatments target specific problems. Raynaud's is managed by keeping the whole body warm and with medicines that widen blood vessels, such as calcium channel blockers or sildenafil; the benefit is real but often modest. Acid-reducing medicines such as proton pump inhibitors ease reflux and swallowing trouble. Pulmonary hypertension is treated with specialized medicines started at a pulmonary hypertension center. Scleroderma kidney crisis is a sudden, steep rise in blood pressure that can damage the kidneys quickly, most often early in diffuse disease. If it develops, an ACE inhibitor (a type of blood pressure medicine) started promptly is the key treatment. Physical and occupational therapy help keep hands and joints moving and can ease pain and fatigue. In adults, doctors use steroids such as prednisone sparingly and at low doses, because higher doses are linked with scleroderma kidney crisis.

What to Expect

Systemic scleroderma is a long-term condition, and its course varies a great deal from person to person. In the diffuse form, the first few years are usually the most active: skin thickening and the risk of new organ problems are greatest early, and the skin often softens gradually afterward. The limited form tends to change more slowly. In either form, organ complications can appear years after diagnosis. It is a serious disease. Lung scarring develops in roughly one in three people and pulmonary hypertension in about one in ten, and these are the most common causes of death from it. That is the reason for regular screening even when you feel well: problems found early have more treatment options. Closer screening and earlier treatment may have improved survival, and many people live long, full lives with the disease. Day to day, systemic scleroderma can affect hand function, eating, digestion, energy and appearance. Digestive symptoms are among the most common and the hardest to treat. Keeping warm, protecting fingers and toes from cuts and pressure, moisturizing skin and using gentle soap substitutes, and hand therapy all help. Fatigue, low mood and sexual difficulties are common and worth raising with the care team, and patient organizations can be a useful source of support. Because the risk of some cancers is higher, keep up with the routine cancer screenings recommended for your age. Pregnancy is possible for many people but is safest when planned at a time the disease is stable and medicines have been reviewed.

When to Seek Help

See a doctor, ideally a rheumatologist, if you have Raynaud's along with puffy or tightening fingers, or Raynaud's together with heartburn, swallowing problems or joint pain that is not explained. If you already have the diagnosis, tell your care team about gradually worsening shortness of breath, a lasting cough, less ability to exercise, swollen legs or worsening digestive symptoms rather than waiting for the next yearly check. Contact your care team the same day if a finger or toe turns dark or black, stays white, cold and painful after warming, or develops an ulcer that is spreading, so they can arrange urgent assessment of the blood supply, ideally within 48 hours. Scleroderma kidney crisis is an emergency. The risk is highest in the first few years of diffuse disease, in people with anti-RNA polymerase III antibodies and after higher-dose steroids, and it often starts as a silent rise in blood pressure. People at higher risk are usually asked to check their blood pressure at home and to agree with their doctor on what reading should prompt action. If your blood pressure is well above your usual readings (especially with new nausea or vomiting), or you develop a severe headache, blurred vision or sudden severe breathlessness even if your reading is normal, go to an emergency department right away and tell staff you have systemic sclerosis, since prompt treatment protects the kidneys. Call 911 for a seizure.

Questions to Ask Your Doctor

  1. 1.Which form of systemic scleroderma do I have, and what do my antibody results suggest about which organs we should watch most closely?
  2. 2.Which screening tests do I need, and how often will we repeat them?
  3. 3.Am I at higher risk of kidney crisis, and should I check my blood pressure at home? What reading should make me act?
  4. 4.What benefits and risks can I realistically expect from the treatment you are recommending, and how will we know it is working?
  5. 5.If I want to become pregnant, how should we plan around my disease and my medicines?

Last reviewed • Oct 2026

Educational content, not medical advice.